Vigene Biosciences’ mission is to make gene therapy affordable. On basic research side, Vigene is developing, manufacturing, and distributing state-of-the-art AAV, lentivirus and adenovirus based reagents including HHMI/Janelia Research Campus AAV Biosensors. On the cGMP clinical production side, Vigene is combining the proven production technologies with rigorous regulatory compliant cGMP production to meet the needs and expectations of clinical material clients. Vigene offers FDA and EMA compliant cGMP production for lentivirus, adenovirus and AAV. Headquartered in Rockville, MD, Vigene is a leader of both research grade and cGMP grade AAV, lentivirus and adenovirus, serving over 2000 academic, biotech and pharmaceutical labs.